Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum

The antimicrobial biocide triclosan [5-chloro-2-(2,4-dichlorophenoxy)phenol] potently inhibits the growth of Plasmodium falciparum in vitro and, in a mouse model, Plasmodium berghei in vivo. Inhibition of [14C]acetate and [14C]malonyl-CoA incorporation into fatty acids in vivo and in vitro, respectively, by triclosan implicate FabI as its target. Here we demonstrate that the enoyl-ACP reductase purified from P. falciparum is triclosan sensitive. Also, we present the evidence for the existence of FabI gene in P. falciparum. We establish the existence of the de novo fatty acid biosynthetic pathway in this parasite, and identify a key enzyme of this pathway for the development of new antimalarials.

[1]  J. Ganguly.  Studies on the mechanism of fatty acid synthesis. VII. Biosynthesis of fatty acids from malonyl CoA. , 1960, Biochimica et biophysica acta.

[2]  Dünnschichtchromatographie von fettsäuren auf silanisiertem kieselgel , 1968 .

[3]  S. Wakil,et al.  Studies on the mechanism of fatty acid synthesis. 18. Preparation and general properties of the enoyl acyl carrier protein reductases from Escherichia coli. , 1968, The Journal of biological chemistry.

[4]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .

[5]  S. Ōmura,et al.  Inhibition of fatty acid synthetases by the antibiotic cerulenin. , 1972, Biochemical and biophysical research communications.

[6]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[7]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[8]  G. Holz,et al.  Lipids and the malarial parasite. , 1977, Bulletin of the World Health Organization.

[9]  Howard M. Rawnsley,et al.  Clinical biochemical and hematological reference values in normal experimental animals , 1977 .

[10]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[11]  T A McKeon,et al.  Purification and characterization of the stearoyl-acyl carrier protein desaturase and the acyl-acyl carrier protein thioesterase from maturing seeds of safflower. , 1982, The Journal of biological chemistry.

[12]  M. Pfaller,et al.  Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex , 1982, Antimicrobial Agents and Chemotherapy.

[13]  K. Haldar,et al.  Acylation of a Plasmodium falciparum merozoite surface antigen via sn-1,2-diacyl glycerol. , 1985, The Journal of biological chemistry.

[14]  M. Tombs,et al.  Induction purification and characterization of NADH-specific enoyl acyl carrier protein reductase from developing seeds of oil seed rape (Brassica napus) , 1986 .

[15]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[16]  A. Singhal,et al.  Functional drug targeting to erythrocytes in vivo using antibody bearing liposomes as drug vehicles. , 1987, Biochemical and biophysical research communications.

[17]  G. Högenauer,et al.  envM genes of Salmonella typhimurium and Escherichia coli , 1989, Journal of bacteriology.

[18]  G. Padmanaban,et al.  Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Padmanaban,et al.  de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. , 1992, Biochemical and biophysical research communications.

[20]  B. Leitinger,et al.  Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli. , 1994, The Journal of biological chemistry.

[21]  O. Dussurget,et al.  Rapid, sensitive PCR-based detection of mycoplasmas in simulated samples of animal sera , 1994, Applied and environmental microbiology.

[22]  R. Fleischmann,et al.  The Minimal Gene Complement of Mycoplasma genitalium , 1995, Science.

[23]  R. Heath,et al.  Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli(*) , 1995, The Journal of Biological Chemistry.

[24]  H. Bergler,et al.  The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. , 1996, European journal of biochemistry.

[25]  C. Rock,et al.  Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. , 1996, Biochimica et biophysica acta.

[26]  H. Hilbert,et al.  Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. , 1996, Nucleic acids research.

[27]  P. A. Leonard,et al.  Triclosan: applications and safety. , 1996, American journal of infection control.

[28]  T. McCutchan,et al.  Inhibition of Plasmodium falciparum Protein Synthesis , 1997, The Journal of Biological Chemistry.

[29]  D. Roos,et al.  Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Heath,et al.  Broad Spectrum Antimicrobial Biocides Target the FabI Component of Fatty Acid Synthesis* , 1998, The Journal of Biological Chemistry.

[31]  S. Levy,et al.  Triclosan targets lipid synthesis , 1998, Nature.

[32]  Shmuel Razin,et al.  Molecular Biology and Pathogenicity of Mycoplasmas , 1998, Microbiology and Molecular Biology Reviews.

[33]  H. Vial,et al.  Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. , 1998, Blood.

[34]  D. Kwiatkowski,et al.  Implications of mycoplasma contamination in Plasmodium falciparum cultures and methods for its detection and eradication. , 1998, Molecular and biochemical parasitology.

[35]  H. Lichtenthaler,et al.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. , 1999, Science.

[36]  Antoni R. Slabas,et al.  Molecular basis of triclosan activity , 1999, Nature.

[37]  R J Heath,et al.  Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis* , 1999, The Journal of Biological Chemistry.

[38]  A. Alcina,et al.  The cloning and expression of Pfacs1, a Plasmodium falciparum fatty acyl coenzyme A synthetase-1 targeted to the host erythrocyte cytoplasm. , 1999, Journal of molecular biology.

[39]  Y. Naot,et al.  Molecular Biology and Pathogenicity of Mycoplasmas , 1998, Microbiology and Molecular Biology Reviews.